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REVIEWS

Model or meal? Farm animal
populations as models for infectious
diseases of humans
Cristina Lanzas*, Patrick Ayscue*, Renata Ivanek‡ and Yrjö T. Gröhn*

Abstract | In recent decades, theory addressing the processes that underlie the dynamics of
infectious diseases has progressed considerably. Unfortunately, the availability of empirical
data to evaluate these theories has not grown at the same pace. Although laboratory animals
have been widely used as models at the organism level, they have been less appropriate for
addressing issues at the population level. However, farm animal populations can provide
empirical models to study infectious diseases at the population level.
Infectious period
The time period during which
an infectious individual is able
to transmit the pathogen to a
susceptible host. The duration
of the infectious period is
exponentially distributed in
deterministic models, in which
the rate of infected individuals
leaving the infectious class is
constant, and in stochastic
models, in which each
infectious individual has a fixed
duration of infectiousness
drawn from an exponential
distribution at random.
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Worldwide, infectious diseases account for more than a
quarter of human deaths annually 1. The emergence and
re-emergence of infectious pathogens and the continuing
struggle to manage other diseases emphasize the challenges facing public health professionals. The optimism
that marked an era when scientists were confident in
the success of eradication efforts and declared victory in the
fight against infectious agents has long since passed.
The complex interactions among processes acting at
different organizational levels that underlie the dynamics of infectious diseases are now becoming evident.
Mathematical models are central in providing insight
into such complex interactions and in understanding why
interventions that have a benefit for an individual may not
ultimately be optimal for the population (for example, the
use of antimicrobials). Mathematical models based on ecological and evolutionary theory have been used to study
pathogen invasion, persistence and evolution in human
populations2. The predictions generated by these models have been pivotal tools in the process of public health
decision making, forecasting the long-term epidemiological and economical consequences of intervention strategies. For example, mathematical models that examined
strategies to mitigate the impact of an influenza pandemic
have shaped the guidelines for preparedness and response
to such an event3. In the absence of long-term follow-up
clinical studies, mathematical models have also helped to
evaluate the efficacy and delivery strategies of vaccines
against human infections by pathogens such as human
papilloma virus4, HIV5 and mycobacteria6. BOX 1 outlines
the steps in the development of a mathematical model.
Mathematical modellers provide hypotheses with
a rigorous test, but the models that they use often rely
on untested assumptions. Empirical data are crucial for

assessing whether these assumptions hold true and for
determining the conditions under which model predictions are valid. For example, a common assumption
of infectious disease models is that the infectious period
is exponentially distributed, and theoretical studies
have shown that changing this assumption has a profound impact on the predicted infection dynamics7,8.
Furthermore, assuming that the infectious period is
exponentially distributed is not realistic for some diseases9. Nevertheless, data on how infectious periods
vary with factors such as pathogen strain, route of excretion or initial infective dose are very limited, thus the
exponentially distributed infectious period remains a
routine assumption of models. Similarly, the transmission–
virulence trade-off hypothesis has been the basis for most of
the theory that has been developed through mathematical modelling of evolutionary epidemiology for the past
three decades10, but this hypothesis has been increasingly
challenged owing to the lack of empirical evidence11.
Both examples underscore the importance of combining
mathematical models and empirical data. The fields of
experimental and mathematical epidemiology have been
linked from their beginnings. In 1936, Greenwood et al.12
published the first quantitative transmission experiments, which were analysed the same year by Kermack
and McKendrick in their highly influential series on the
mathematical theory of epidemics13,14.
Empirical data can be obtained from field or experimental settings using biological models of animal diseases. Although these animal models have been widely
used to explore pathology and pathogen dynamics at the
cell and individual animal levels, their use to describe
population-scale disease dynamics and their feedback
interactions has been limited. Appropriately designed
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of drug resistance and virulence or to inform vaccine
design requires animal models in which the interactions
a
between processes acting at different organizational levels
(for example, within a host and between hosts) can be
quantified15.
The search for appropriate biological models to study
infectious disease dynamics has often overlooked promising systems that are available in animal agriculture.
Mathematical models in farm animal populations have
been largely limited to offering guidance to veterinary
decision making for pressing food protection, animal
welfare and economic issues, such as those presented
b
in outbreaks of bovine spongiform encephalopathy 16 or
Susceptible
Infectious
Recovered
animals
animals
animals
foot-and-mouth disease17. We propose that farm animal
populations, coupled with mathematical models, are
Infection
Contamination
well-suited model systems to study infectious-disease
Contaminated
Uncontaminated
population dynamics and problems that span several
workers
workers
levels of organization and that are relevant to the control
of human infectious diseases. We discuss the features,
Mathematical modelling facilitates inference from biological model systems. There are
advantages and disadvantages of these systems and highReviews | Microbiology
four steps in the modelling of an infectious disease, illustratedNature
by the following
outline
light research areas that might benefit from the knowlof the steps used for the modelling of a multidrug-resistant Salmonella enterica subsp.
enterica serovar Newport (S. Newport) outbreak in a calf-raising facility (see the figure;
edge generated by studying infectious disease dynamics
part a shows the prevalence and location of the affected animals in the outbreak, with
in farm animal populations.
green indicating clinical cases and red indicating deaths, and part b shows a flow
diagram representation of the model)23.
Farm animals as natural infection model systems
Formulate the research question
In this section, we discuss the key features of the farm
The most important step in modelling is the formulation of the research questions. These
animal systems that are relevant to infectious disease
questions provide criteria to help researchers decide which elements of the system under
dynamics, with emphasis on the similarities and differstudy must be included in the model. In the case of the S. Newport outbreak, these
ences between farm animals and humans at the populainclude questions such as: what factors contribute to the transmission and persistence
tion level (BOX 2). Pathogen–host systems in which the
of the outbreak, and what are the best control strategies to stop outbreaks?
pathogen is studied in its natural host are necessary to
Develop the mathematical model
investigate infectious disease dynamics at the population
To develop a mathematical model, the variables and assumptions to be included in the
level. In surrogate models, the pathogen does not natumodel need to be defined. Then a flow diagram is drawn to describe the changes to
rally infect the host animal outside a laboratory setting,
these variables over time. The modeller must then decide whether a deterministic or
and high doses of the pathogen administered through
stochastic model is appropriate and write the mathematical equations. The animals in
artificial transmission routes are often necessary to induce
the calf-raising facility are individually penned animals (see the figure, part a), and
infection18. These issues complicate the study of pathogen
therefore transmission of the pathogen is through contaminated fomites and mechanical
vectors. In this situation, an indirect SIR transmission model (which classifies individuals
transmission in the surrogate model, because it may not
as susceptible, infectious or recovered) is appropriate, in which the host population is
take place at all or it may result in invalid measures of
divided according to their epidemiological status.
pathogen life history traits such as the duration of the
infectious period. laboratory animals, especially mice,
Analyse the mathematical model
Based on simulations, a model analysis is chosen that best addresses the problem.
have been the main animal models for studying specific
Threshold values and conditions for invasion and persistence of the pathogen are
aspects of human pathogenesis and immunity. However,
evaluated and scenarios simulating control strategies are run.
mice are more often surrogate models than natural
Validate the mathematical model
models for the pathogen under study. At the individual
The results of the simulations are checked against data or known cases. Alternatives to
level, farm animals are being used as natural models for
the model and to the assumptions are considered.
a wide range of human infectious diseases (TABLE 1). In
relate the model back to the research question
many cases, humans and farm animals share pathogens.
The results from the previous step are interpreted to assess whether the results
More than half of human infectious diseases are caused
answer the research question. During the outbreak of S. Newport, environmental
by multihost pathogens19, for which farm animals are
reservoirs, the high turnover rate of individuals and the continual admission of
often natural hosts and serve as an important infection
susceptible individuals favour persistence. Immunization of a high proportion
reservoir for humans20. Farm animals are therefore good
of admitted individuals (>75%) and completely closing off facilities to reduce
candidates for studying infectious disease dynamics at
the effective contact rate by allocating personnel and equipment to subgroups
the population level.
were effective strategies to control outbreaks.
There are many similarities in the underlying principles that govern infection transmission in human and
studies involving animal models should also be used to farm animal populations, which allows us to use the aniimprove our understanding of the impact of treatments mal system as a model. At the population level, livestock
and control strategies and the evolutionary dynamics production systems include a range of population settings
of pathogens that take place at the population level. In and contact structures, including backyard poultry flocks,
addition, attempting to predict or control the evolution highly extensive herds and highly controlled production
Box 1 | Developing a mathematical model
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Box 2 | Features of farm animal populations that are relevant to their potential use as models
• The disease mechanisms and immune systems are sufficiently similar between some farm animals and humans.
• The populations are outbred.
• Natural transmission takes place, and quantification of life history traits, including infectious period and transmission rate,
is feasible.
• The populations are highly stratified with multiple sources of heterogeneity (for example, spatial, genetic and
management factors and age) that can be readily manipulated.
• We have extensive knowledge of the host–pathogen systems.
• Diverse interventions are logistically and ethically feasible.
• Long-term interventions such as mass vaccination programmes are applied.

Transmission–virulence
trade-off hypothesis
The proposal that increased
host survival and, therefore,
pathogen transmission
represent a trade-off for the
parasite: high parasite
reproduction in the host and
high levels of virulence can
cause host death, reducing the
chances of the parasite being
transmitted to another host.

Stochastic model
A mathematical model that
incorporates elements of
chance. Stochastic models are
necessary when small
populations, such as those in a
transmission experiment, are
being modelled.

Organizational level
Living entities are organized in
hierarchical levels (for example,
cell, individual, population and
ecosystem). Each level of
organization builds on the level
below it but often has
emergent properties (that is,
properties that result from the
interactions between the parts
of the level below).

management systems. Factors that contribute to animal
disease outbreaks (for example, crowding, close contact,
poor hygiene and contaminated fomites) are common to
human settings such as hospitals, army camps, schools,
daycare facilities and dense urban areas21,22. From a population dynamics point of view, both calf-rearing units
and health care settings are small, transient populations;
a high turnover rate of individuals in the facility, the
presence of environmental reservoirs of infection and
continuous antimicrobial selective pressure prolong the
transmission of multidrug-resistant clonal pathogens in
both situations23,24. Furthermore, heterogeneities that
lead to differences in infectiousness and transmission
dynamics are often similar across different combinations
of hosts and pathogens25. Factors that influence the infection process and transmission dynamics in both animals
and humans include age, nutritional health, vaccination
history, physiological state and genetic heterogeneity of
the host, as well as environmental factors such as hygiene
and the type of social interactions and contacts that occur
in the population. It should be noted, however, that at
certain spatial scales transmission dynamics between
farm animals and human populations may not be comparable. For example, transmission at large spatial scales
can be dissimilar, as networks of livestock and human
movements can differ substantially 26. In addition, the
progress made in our understanding of those farm animal diseases that have wildlife reservoirs (for example,
bovine tuberculosis) has been slowed owing to the difficulties in characterizing transmission between domestic
and wild animals.
In agricultural systems, decisions regarding the
use of intervention strategies are based on individual
and population health (of both the animals and their
human carers), animal welfare, food safety and economic considerations. Because of the need to balance
these considerations, infectious disease management
makes use of diverse control options; for example, vaccines that do not prevent transmission but do reduce
clinical disease are used to reduce the economic burden
of diseases27. Vaccines with diverse modes of action (for
example, inhibition of pathogen growth rate or toxicity, or
blocking transmission) and a range of vaccination strategies (for example, cohort or continuous vaccination)
are used for farm animals. other control strategies used
for animal diseases include surveillance, environmental
hygiene, ‘all-in, all-out’ management (in which animals
are managed in groups, and cleaning and sanitation of

facilities is carried out before introducing a new group)
and targeting of specific groups (for example, the detection and treatment (‘test and treat’) or culling (‘test and
cull’) of infected animals)28. The wide range of available
control strategies for farm animal diseases has contributed to the unravelling of infectious disease dynamics. For
instance, endemic stability is an epidemiological concept
that is well described in veterinary medicine, especially in
tick-borne diseases, and that may also be relevant to the
control of a wider range of diseases, including malaria or
dengue in humans. At endemic stability, the clinical disease prevalence is low despite high levels of infection in
the population, because immunity is acquired at a young
age, when the disease is milder 29. Decreasing transmission increases the age at which animals become infected,
thus increasing the percentage of infections that result in
clinical disease. Not controlling infection transmission is
considered a more sustainable option than partial control in this case, because higher transmission rates result
in lower clinical disease levels. It was hypothesized that
endemic stability could be observed in all human and
animal diseases for which the probability or severity of
clinical disease increases with age and the probability
of disease is reduced after two or more infections29. This is
illustrated by the results of the control measures that were
taken for dengue. Dengue is a mosquito-borne viral disease that can cause symptoms ranging from mild fever to
life-threatening haemorrhagic fever. For decades, several
Asian countries, including Thailand and Singapore, have
applied vector control programmes to control dengue.
Despite these measures, the incidence of dengue cases has
not declined. The stagnant incidence was initially attributed to the failure of the vector control programmes to
decrease transmission, but analysis of the epidemiological
data revealed that virus transmission has decreased, and
the increase in dengue cases at lower transmission rates
may result from the loss of endemic stability 30,31.

Infectious disease dynamics in farm animals
To study the complex processes underlying infectious
disease dynamics, approaches that integrate different
fields and methods are required. By gathering scientific
evidence about the host–pathogen systems through
experimental, field, model and historical investigations
at different organizational levels, a complete picture of
the causal mechanisms shaping the infection dynamics
can be uncovered32. using challenge and transmission
experiments carried out in animal agriculture systems,
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Table 1 | Farm animal models for human pathogens or diseases
Animal pathogen

Farm animal
hosts

Human disease or
pathogen

Examples of studied disease
processes

Bovine papilloma
viruses

Cattle

Human papilloma
viruses

Latency mechanisms of papilloma
viruses and vaccine development

98

Bovine respiratory
syncytial virus

Cattle (calves)

Human respiratory
syncytial virus

Vaccine development

99

Caprine arthritis
encephalitis virus and
Visna/maedi virus

Goats and sheep

HIV

Genetic susceptibility and
lentivirus–host adaptation

100

Cryptosporidium
parvum

Cattle (calves) and
swine (piglets)

Cryptosporidium
parvum

Therapeutic treatment testing and
clinical responses to diverse strains

101

Hepatitis E virus

Swine and chickens

Hepatitis E

Mechanisms of pathogenesis and
vaccine development

102

Marek’s disease virus

Chickens

Virus-induced
lymphoma

The role of immune control and
evasion in neoplasma formation
and mechanisms of virus-induced
lymphoma

48

Mycobacterium bovis

Cattle, goats and
swine

Human tuberculosis

Mechanisms of pathogenesis, host
defences and vaccine development

Salmonella enterica

Cattle (calves)

Human enteritis

The role of virulence factors
on infection and S. enterica
pathogenesis

large-scale and long-term field data can be gathered on
the same host–pathogen system, and thus model systems
that span several organizational levels can be obtained.
understanding infectious disease dynamics often
requires gathering data to estimate virulence, infectiousness and transmission, and such data can be obtained from
farm animal populations. Pathogen excretion has been
more readily quantified in farm animals than in humans.
Listeria monocytogenes infection in cattle has been used as
a biological model to develop a mathematical approach to
quantify the duration and frequency of shedding episodes
for pathogens that have an oral–faecal mode of transmission33; this is a route of transmission for many important
human infectious agents, including Salmonella and hepatitis A virus. Transmission information can be obtained
from experiments or field studies, which are often used
to test interventions such as vaccination. Experimental
studies testing vaccines have characterized their effects at
both the individual and population levels34 using group
or one-to-one transmission experiments (FIG. 1). Statistical
methods based on stochastic transmission models have
been developed to quantify transmission parameters and
pathogen life history traits35. In controlled conditions, the
contribution of specific aspects affecting transmission can
also be studied35. The effect of expressing an F4 receptor for intestinal adhesion of the F4 fimbrial antigen of
Escherichia coli on the susceptibility and infectivity of piglets to E. coli infections was quantified by testing all possible combinations in one-to-one experiments, in which
one infectious animal (either positive or negative for the
F4 receptor) was housed with one susceptible animal
(either positive or negative for the F4 receptor)36. F4 receptor-positive piglets were more susceptible, and the maximum proportion of F4 receptor-positive piglets that can
be present in a population without outbreaks occurring
was estimated to be 0.14.

refs

103,104
105

Quantitative experiments in veterinary medicine using
farm animals have linked transmission measurements
to within-animal dynamics (for example, the pathogen
load and the immune response)37–39, and thus detailed
information such as time-dependent infectiousness can
be quantified40. Combined quantitative information
about within-host dynamics and transmission is crucial
to parameterize and validate mathematical models that
seek to understand pathogen evolution.
using field and historical data, the long-term effects of
control strategies can be investigated. In field studies, animal productivity and health databases are often available
and can provide extensive information on health, management and disease control. It is not unusual for a typical
farm to know at any given time exactly how many animals
are present, the density at which they have been held, what
they are eating and drinking, their deep geographic and
genetic pedigrees, their clinical disease states and histories, their ages and how these age-structured classes have
been stratified, and measures of their performance and
production in detail. In human and wild-animal systems,
information regarding movements, density, contacts and
even population size are often unknown, even to an order
of magnitude. In farm animals, information at lower hierarchical levels (such as at the organ or tissue level) can
be gathered by biological and post-mortem sampling.
Biological sampling can be performed on a regular basis
and can be accomplished easily, with minimal disturbance
to the animals; necropsies are commonly performed on
either culled or dead animals, and carcasses are inspected
at the abattoir. owing to legal requirements, data describing the network of animal movements between farms are
available in some countries. Combined, these data provide
far richer information about infectious diseases dynamics across scales than is typically available in wildlife or
human systems.
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Host–pathogen model systems in farm animals
An outline of some areas of fruitful work using animal
agricultural models is presented in TABLE 2, with emphasis on those models that are relevant to human health,
and we briefly discuss some examples of these research
areas below.
Vaccine research. Vaccination has been a very successful control strategy for several diseases, including yellow fever, hepatitis A and childhood diseases, providing
life-long immunity. However, vaccines are now being
developed for human and animal pathogens that have
fast antigen variability (for example, the influenza virus)
or short natural immunity (for example, malaria parasites) or that induce a cell-mediated immune response
(for example, HIV and Mycobacterium tuberculosis). For
these pathogens, the available vaccines are imperfect, as
they do not stop individuals from becoming infected on
exposure to the pathogen. Imperfect vaccines can alter
the selective pressures imposed on pathogens and, thus,
potentially alter the evolution and composition of pathogen communities41. Mathematical models investigating
the evolutionary consequences of the use of imperfect
vaccines have been developed in recent years42–44. These
models have investigated the short-term and long-term
evolution of a pathogen under vaccine pressure and have
suggested that vaccines reducing the fitness cost of virulence (for instance, by reducing host death) may favour the
spread of more virulent strains in the vaccinated population. It was concluded that vaccines that are designed to
reduce pathogen growth rate or toxicity could lead
to increased pathogen virulence42, which could cause
a
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Figure 1 | Designs of transmission experiments. a | One-to-one experiments. One
Nature Reviews | Microbiology
infectious animal (I) is housed with one susceptible animal (S)96. A transmission chain can
be obtained by using the infected animals to infect the next generation of susceptible
animals. b | Group experiments. A number of infectious and susceptible animals are
housed together97. c | Extended transmission experiments. Artificially inoculated animals
are mixed with susceptible animals. Artificially inoculated animals are removed, and the
newly infectious animals (yellow and green), infected by contact with the inoculated
animals, are used to start the transmission experiment by mixing them with new
susceptible animals (blue)39. This design is useful when the artificial inoculation creates
highly infectious animals; however, the initial infection process is less controlled. Aspects
that need to be considered in the design of the experiment are the infection route,
inoculation dose, mathematical model and statistics used to infer transmission parameters.

more severe disease in unvaccinated individuals. To
predict the direction and speed of evolution, measures
of the life history traits (including the transmission rate,
the infectious period and virulence) in both vaccinated and
naive hosts are necessary 44. Tracking virulence changes in
humans is difficult, as exposing humans to virulent strains
is unethical, and historical data is confounded by changes
in factors such as medical treatments45.
Except for laboratory experiments with rodent
malaria46, the only reported cases of increased virulence
for a pathogen under vaccine selective pressure have
been in domestic animals. In commercial chickens, two
generations of vaccines against Marek’s disease virus have
been abandoned (reviewed in REF. 47). Marek’s disease,
caused by an alphaherpesvirus, is a lymphoproliferative
disease that has caused major economic losses to the
poultry industry owing to its high morbidity and mortality 47. The first vaccine against Marek’s disease virus was
introduced in 1969, but in the late 1970s a more virulent
pathotype emerged and prompted the deployment of a
new vaccine. In the early 1990s another virulence shift
took place, followed by the development of a new vaccine47. The evolved mutants have the same epitopes as
strains from the pre-vaccine era but have shown greater
viral replication and higher immunosuppressive capabilities47. Marek’s disease is a unique empirical model
to study virulence evolution in vaccinated populations.
Marek’s disease in chickens is already used as an animal
model to study vaccine immunity to cancer and viralinduced oncogenic transformations48. New knowledge
in evolutionary epidemiology may lead to the inclusion
of evolutionary considerations in vaccine design and
development.
Antimicrobial resistance. The increase in the prevalence
of infections that are caused by antimicrobial-resistant
organisms is linked to the intensity of the selection that
is imposed by the use of antimicrobials, and therefore
infections with antimicrobial-resistant bacteria are especially common in health care facilities and on farms,
where antimicrobial use is intensive. Transmission of
clones of resistant bacteria between individuals is key
for the dissemination and persistence of antimicrobialresistant pathogens, both in health care facilities49,50
and on farms51. The decrease in antimicrobial pressure
has not always resulted in a decrease in antimicrobialresistant bacteria at the population scale, however52.
The mechanisms and determinants responsible for the
persistence of antimicrobial resistance remain largely
unknown, although several mechanisms have been postulated, including compensatory mutations that reduce
or revert fitness costs53, co-selection with heavy metals
and biocide resistant genes54, and increased horizontal
gene transfer under stress responses55. The determinants
leading to the persistence of antimicrobial resistance can
be studied systematically in farm settings, because the
suspected determinants can be manipulated at the population level. For example, the determinants responsible
for the persistence of commensal E. coli that is resistant
to streptomycin, sulphonamide and tetracycline in dairy
calves were investigated in a series of studies56–59. Three

NATurE rEVIEWS | Microbiology

VoluME 8 | FEBruAry 2010 | 143
© 2010 Macmillan Publishers Limited. All rights reserved

REVIEWS
Table 2 | The use of farm animal populations to study infectious-disease dynamics
research area

Animal pathogen or disease

Animal model or system refs

Marek’s disease

Poultry

47

Infectious bursal disease

Poultry

106

Avian influenza

Poultry

107

Foot-and-mouth virus

Ruminants

108

Salmonella enterica

Swine, dairy cows and
poultry

109

Multidrug-resistant Salmonella spp. strains

Dairy cows

Vaccine research
Evolution of pathogen virulence and
antigenic escape

Vaccine design for multistrain or
multihost pathogen systems

Antimicrobial resistance
Emergence and persistence of
resistance

Methicillin-resistant Staphylococcus aureus Swine

110
N/A

Escherichia coli

Swine and dairy cows

63

Feedback between the within-host
pathogen dynamics and transmission

Foot-and-mouth virus

Ruminants and swine

69

Empirical testing of transmission rate
formulations and contact patterns

Multiple pathogens

Closed herds

35

Effect of infection imports on
occurrence, frequency and
persistence of disease outbreaks

Multiple pathogens

Connected open herds

111

Genetic determinants of vaccine
responses

Foot-and-mouth virus

Ruminants

112

Marek’s disease

Poultry

47

Genetic determinants of disease
susceptibility

Marek’s disease

Poultry

48

Nematode parasites

Sheep

75

Trypanosoma congolense and
Trypanosoma vivax

Cattle

113

E. coli

Swine

36

Bovine respiratory disease complex

Cattle

114

Porcine gastroenteritis

Swine

115

Transmission dynamics

Host heterogeneity

Dynamics of polymicrobial diseases
Dynamics of multiple colonizations
and transmission dynamics

Emergence of new strains and cross-species infections
Mechanisms of emergence of
new strains and cross-species
transmission

Avian influenza

Live-bird markets

Hepatitis E

Swine

102

94

Influenza

Swine

82

Johne’s disease

Dairy cows

28

Mastitis

Dairy cows

116

Dynamics of chronic infections
Dynamics of host–pathogen
interactions and the determinants of
persistence at the population level
N/A, not applicable.

hypotheses were tested: that the direct antimicrobial
selection pressure maintains the high prevalence of the
resistant strain; that the resistant strain provides a secondary advantage; and that a milk supplement (skimmed
milk with vitamins D and A) provides a selective advantage. The persistence of the resistant E. coli in calves was
found to be linked to the consumption of the vitamin D
that was present in the milk supplements56–58. These
studies showed that there can be a causal link between
factors other than antimicrobial presence and the
persistence of the antimicrobial resistance.

Field studies have been used to monitor the persistence of antimicrobials after the reduction of their use
in farms. Antimicrobial pressure on farms ranges from
non-existent (in antimicrobial-free farming systems)
to high levels, as antimicrobials are used at different
doses depending on the purpose (for example, therapeutic versus growth promoter uses). Studies comparing conventional and organic farms have shown that
the level of antimicrobial resistance of enteric bacteria
was lower on organic farms than on conventional farms,
but that the difference in levels varied depending on the
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antimicrobial60–62. The influence of antimicrobial selection on the genetic composition of E. coli populations
was studied by comparing E. coli isolates from both
organic and conventional farms63. organic farm isolates had lower ampicillin resistance than conventional
farm isolates, which showed clonal resistance, but tetracycline resistance persisted in organic farms, probably
owing to genetic hitchhiking. Such studies can aid in predicting when antimicrobial reduction policies might be
successful in human populations, as well as helping to
determine the time that is necessary for antibiotic resistances to revert. In this regard, longitudinal studies of
herds undergoing the transition to organic farming, in
which antimicrobial resistance and the genotypes of the
pathogens found in the farm are characterized, would
be especially helpful.

Genetic hitchhiking
A process in which alleles
increase their frequency in the
gene pool because they are
associated with alleles at
genetically linked loci that
are favoured by selection.

Overdispersed
Pertaining to a distribution with
a variance that is greater than
the mean. For parasites, this
occurs when many hosts
harbour a few parasites and
a few hosts harbour a large
number of parasites.

Basic reproduction number
The expected number of
secondary cases infected by
transmission from a typical
infected individual during that
individual’s entire period of
infectiousness in a completely
susceptible population.

Reassortment
The exchange of genetic
material between genetically
different viruses that are
infecting the same cell. It can
result in the generation of a
novel strain.

Transmission dynamics. Transmission is the key process underlying infectious disease dynamics. Infectious
disease models use varying transmission formulations
that convey different assumptions about the structure of
contacts among individuals of the population and their
scaling with population density 64. The predictions of the
models can vary greatly when different transmission
formulations are used, but empirical studies comparing
these formulations are limited65. In human populations,
the scaling of transmission rates with host population
size and type of mixing (that is, homogeneous or heterogeneous) has only been assessed for measles, for which
there are good data records for both large and small
communities66. Experimental transmission studies in
farm animals have evaluated the effect of density and the
scaling of contact-based transmission67,68. understanding
how pathogen transmission in a population is affected
by the pathogen dynamics within the host is important for predicting outbreaks and pathogen evolution15.
Quantitative data linking both scales are limited, but
some studies in veterinary medicine suggest that small
differences in the observed duration of latent and infectious periods for the individual host can result in large
differences in pathogen transmission at the population
level37. latent and infectious periods were estimated for
equine influenza viruses in animals vaccinated with a
homologous (immunologically identical) strain or
a heterogenous (immunologically similar but not identical) strain. Vaccine escape, occurring in animals vaccinated with the heterogeneous strain, increased the
duration of the infectious period. Studies that quantify
transmission and within-host dynamics have also been
conducted for foot-and-mouth disease in different species69, which provided unique data on a pathogen’s life history traits, including the relationship between pathogen
load and transmission.
Host heterogeneity. Pareto’s law is pervasive in transmission dynamics; it states that 20% of infected individuals contribute 80% of the net transmission for a
wide range of diseases25. Transmission is influenced
by many sources of heterogeneity, including behavioural and genetic factors, age, vaccination status and
nutrition70,71. untangling the causes and providing an

accurate representation of the population heterogeneity in models are important ongoing challenges in the
study of infectious disease transmission dynamics and
control71. A notable implication of the presence of heterogeneity on infection transmission is that individualspecific control measures designed to target the most
infectious individuals (such as isolation) or susceptible
individuals (such as vaccination of high-risk individuals) are more efficient at controlling the transmission
than population-wide control measures (such as vaccination at random)25,71. The distribution of helminth
parasites between hosts is usually highly overdispersed72;
in humans the relative roles of exposure and genetic
resistance in generating the overdispersed distribution
is unknown73. Arguably, gastrointestinal nematodes in
livestock are one of the best understood of all host–
parasite systems, and extensive research to determine
the sources underlying helminth overdispersion has
been conducted74,75. A detailed quantitative genetic
analysis indicated that additive genetic variation was
the most important source of variability in faecal egg
counts in sheep76. Two loci accounted for a large portion
of the additive variation: the interferon-γ gene (IFNG)
and the major histocompatibility complex class II
Dr β-chain locus (DRB1)75. Genetic approaches are
now being integrated with epidemiological models in
order to quantify the contributions of the non-genetic
and genetic variations in host immune responses to the
observed transmission patterns and the impact of these
variations on parasite control77.
Emergence of new pathogens. The interest in the emergence of new infectious diseases has grown considerably
owing to highly publicized cases such as highly pathogenic avian influenza, swine-origin H1N1 influenza A
and severe acute respiratory syndrome (SArS). The
emergence of infectious diseases can be seen as a fourstep process78: exposure of a new host to the pathogen,
infection of the new host, transmission within the new
host population, and epidemic spread. Although there is
agreement that both ecological and evolutionary factors
contribute to this process, their specific contributions to
driving the basic reproduction number above 1 and to the
resulting epidemic spread in the new host is unknown.
In addition, it is unclear at which step the evolutionary
changes that favour crossing species barriers or transmission in the new host take place79. Monitoring the transmission dynamics and the emergence of new pathogens
among animals in agricultural systems provides an opportunity to study the mechanisms underlying emergence
and to identify areas and pathogens from which the next
human emerging infectious disease is likely to originate.
Influenza viruses in farm animal populations not only
serve as multiscale models for human disease, but also are
major components of the natural system driving disease
evolution and emergence into the human population.
The emergence of new influenza viruses is caused
by reassortment involving human, swine or avian influenza viruses or by host-switching events in which the
accumulated mutations favour the emergence of new
strains that are capable of crossing species barriers
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Mixed vessel theory
New strains of influenza virus
can emerge if an avian-origin
virus and a human-origin virus
simultaneously infect the same
animal (for example, pigs). This
dual infection can produce
reassortants with pandemic
potential, if the reassortant
has the ability to transmit
effectively through humans and
if humans are immunologically
naive to the new strain.
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2.

3.
4.
5.

6.

and adapting in a new host owing to the low fidelity
of the viral rNA polymerase. Examples of reassorted
viruses in humans include the H2N2 influenza virus
that caused the 1957 outbreak of ‘Asian influenza’
and the H3N2 strain that caused ‘Hong Kong influenza’ in 1968. The deadly H1N1 influenza pandemic
in 1918 was probably due to a host-switching event
and the consequent adaptation of an avian virus to
humans80. During this pandemic, the H1N1 strain was
also introduced into the pig population and evolved
into the classic H1N1 strain that remained the predominant lineage in pigs in North America until the
late 1990s81. In 1997–1998, two distinct H3N2 strain
genotypes were identified in the North American
swine population: a double human virus–swine virus
reassortment and a triple avian virus–human virus–
swine virus reassortment 82. The triple-reassortant
H3N2 strain spread efficiently in the swine population and has continued to evolve by genetic drift and
by reassortment with the classic H1N1 strain83. This
H3N2 strain is one of the progenitors of the newly
recognized 2009 swine-origin H1N1 influenza virus84.
other H1N1, H3N2 and H1N2 influenza virus strains
circulate worldwide in swine populations, although
their origins and nature varies depending on their
geographical location81,85. In addition, transmission
from swine to humans has been well documented
and ranges from sporadic cases with no further
human-to-human transmission86, to limited humanto-human transmission (for example, the Fort Dix
influenza outbreak in 1976)87, to extensive humanto-human transmission (for example, the 2009
swine-origin H1N1 influenza virus)88.
This extensive accumulated knowledge about the
dynamics of influenza viruses in swine populations
and their potential to emerge into human pathogens
makes them a suitable model to study the ecology of
influenza viruses. Comparisons among the influenza
viruses found in swine populations have provided
insights into the molecular basis of influenza transmissibility and the role of swine in the mixed vessel
theory82. Empirical evidence for the three components
of the mixed vessel theory, including the findings that
swine are susceptible to avian and human influenza A
viruses, that reassortment between swine, avian and
human viruses takes place in the pig and that pigs
can transmit reassortant viruses to humans, have
been documented82. Host-switching events have also
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been observed in swine populations. For example,
in 1979 an avian H1N1 strain crossed the species
barrier and established a new lineage in swine. This
lineage provided a model for studying the early evolution of influenza viruses89,90. Comparisons with the
classic swine H1N1 strain, circulating since 1918,
indicated that influenza viruses have weak hostspecific adaptation, as no common genetic changes
related to the host-switching event were identified.
This suggests that we have a limited ability to predict
potential emergent avian influenza viruses by identifying specific polygenic changes that are indicative of
mammalian adaptation89. More recently, other hostswitching events without reassortment have been
described, including other avian-to-swine switches,
such as the H2N3 strain in the united States91, as well as
equine-to-dog switches92.
Surveillance in live-poultry markets serves as an
early warning system of emerging influenza viruses
and has provided another battleground for studying
the ecology of this virus93. live-poultry markets bring
together a number of hosts (including humans) of
multiple origins in a high-density setting. Studies on
the gene pool of the influenza viruses circulating in
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The study of influenza emergence requires the use of
natural mixing patterns, including those observed in
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Conclusions
Infectious diseases in farm animals are often studied
because they represent an economic cost or a zoonotic
risk. Here we present yet a third important reason for
such work: infectious diseases in farm animals can be
used as biological models to provide empirical data that
aids infectious disease modelling and to advance our
understanding of infectious disease dynamics and control for human populations. As rudolf Virchow, father of
the field of pathology, said: “Between animal and human
medicine there is no dividing line — nor should there
be. The object is different but the experience obtained
constitutes the basis of all medicine.” (REF. 95.)
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